These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1258 related articles for article (PubMed ID: 29860762)

  • 1. [Clinical characteristics and prognosis of patients with ipsilateral breast tumor recurrence after breast conservation therapy].
    Sun GY; Wang SL; Tang Y; Jin J; Song YW; Liu YP; Wang WH; Fang H; Chen SY; Ren H; Liu XF; Yu ZH; Li YX
    Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):352-358. PubMed ID: 29860762
    [No Abstract]   [Full Text] [Related]  

  • 2. Analysis of ipsilateral breast tumor recurrences after breast-conserving treatment based on the classification of true recurrences and new primary tumors.
    Komoike Y; Akiyama F; Iino Y; Ikeda T; Tanaka-Akashi S; Ohsumi S; Kusama M; Sano M; Shin E; Suemasu K; Sonoo H; Taguchi T; Nishi T; Nishimura R; Haga S; Mise K; Kinoshita T; Murakami S; Yoshimoto M; Tsukuma H; Inaji H
    Breast Cancer; 2005; 12(2):104-11. PubMed ID: 15858440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical management of ipsilateral breast tumor recurrence.
    Kolben T; Schwarz TM; Goess C; Blume C; Degenhardt T; Engel J; Wuerstlein R; Ditsch N; Harbeck N; Kahlert S
    Int J Surg; 2015 Nov; 23(Pt A):141-6. PubMed ID: 26449651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of treatment for ipsilateral breast tumor recurrence in early-stage breast cancer.
    Dalberg K; Mattsson A; Sandelin K; Rutqvist LE
    Breast Cancer Res Treat; 1998 May; 49(1):69-78. PubMed ID: 9694613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognosis and risk factors of 1 791 patients with breast cancer treated with breast-conserving surgery based on real-world data].
    Chen SY; Tang Y; Song YW; Wang SL; Jin J; Liu YP; Wang WH; Fang H; Ren H; Sun GY; Wang JY; Jing H; Zhang JH; Liu XF; Yu ZH; Li YX
    Zhonghua Zhong Liu Za Zhi; 2018 Aug; 40(8):619-625. PubMed ID: 30139034
    [No Abstract]   [Full Text] [Related]  

  • 6. Local recurrence risk after previous salvage mastectomy.
    Tanabe M; Iwase T; Okumura Y; Yoshida A; Masuda N; Nakatsukasa K; Shien T; Tanaka S; Komoike Y; Taguchi T; Arima N; Nishimura R; Inaji H; Ishitobi M;
    Eur J Surg Oncol; 2016 Jul; 42(7):980-5. PubMed ID: 27055945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving local control with breast-conserving therapy: a 27-year single-institution experience.
    Cabioglu N; Hunt KK; Buchholz TA; Mirza N; Singletary SE; Kuerer HM; Babiera GV; Ames FC; Sahin AA; Meric-Bernstam F
    Cancer; 2005 Jul; 104(1):20-9. PubMed ID: 15912514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of axillary lymph node status on the prognosis of patients with local-regional recurrence after breast-conserving surgery].
    Zhang Z; Zhang W; Li ZJ; Wang XM; Cao XC; Xiao CH
    Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):347-351. PubMed ID: 29860761
    [No Abstract]   [Full Text] [Related]  

  • 9. Ipsilateral breast tumor recurrence after breast conservation therapy: outcomes of salvage mastectomy vs. salvage breast-conserving surgery and prognostic factors for salvage breast preservation.
    Alpert TE; Kuerer HM; Arthur DW; Lannin DR; Haffty BG
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):845-51. PubMed ID: 16199315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy.
    Meric F; Mirza NQ; Vlastos G; Buchholz TA; Kuerer HM; Babiera GV; Singletary SE; Ross MI; Ames FC; Feig BW; Krishnamurthy S; Perkins GH; McNeese MD; Strom EA; Valero V; Hunt KK
    Cancer; 2003 Feb; 97(4):926-33. PubMed ID: 12569592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uncontrolled local disease after salvage treatment for ipsilateral breast tumour recurrence.
    Dalberg K; Liedberg A; Johansson U; Rutqvist LE
    Eur J Surg Oncol; 2003 Mar; 29(2):143-54. PubMed ID: 12633557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer.
    Anderson SJ; Wapnir I; Dignam JJ; Fisher B; Mamounas EP; Jeong JH; Geyer CE; Wickerham DL; Costantino JP; Wolmark N
    J Clin Oncol; 2009 May; 27(15):2466-73. PubMed ID: 19349544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twenty-year outcomes after breast-conserving surgery and definitive radiotherapy for mammographically detected ductal carcinoma in situ.
    Wilkinson JB; Vicini FA; Shah C; Shaitelman S; Jawad MS; Ye H; Kestin LL; Goldstein NS; Martinez AA; Benitez P; Chen PY
    Ann Surg Oncol; 2012 Nov; 19(12):3785-91. PubMed ID: 22644510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ipsilateral breast tumor recurrence (IBTR) in patients with operable breast cancer who undergo breast-conserving treatment after receiving neoadjuvant chemotherapy: risk factors of IBTR and validation of the MD Anderson Prognostic Index.
    Ishitobi M; Ohsumi S; Inaji H; Ohno S; Shigematsu H; Akiyama F; Iwase T; Akashi-Tanaka S; Sato N; Takahashi K; Oura S
    Cancer; 2012 Sep; 118(18):4385-93. PubMed ID: 22252882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omission of axillary surgery for ipsilateral breast tumor recurrence with negative nodes after previous breast-conserving surgery: is it oncologically safe?
    Qu FL; Lin CJ; Liu ZB; Cao AY; Wu J; Liu GY; Yu KD; Di GH; Li JJ; Shao ZM
    Breast Cancer Res Treat; 2022 Nov; 196(1):97-109. PubMed ID: 36040640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classification of ipsilateral breast tumor recurrence after breast-conserving therapy: new primary cancer allows a good prognosis.
    Nishimura S; Takahashi K; Akiyama F; Oguchi M; Tada K; Makita M; Iwase T; Yoshimoto M; Yamashita T; Sakamoto G; Kasumi F
    Breast Cancer; 2005; 12(2):112-7. PubMed ID: 15858441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.
    Choi YJ; Shin YD; Song YJ
    World J Surg Oncol; 2016 Apr; 14():126. PubMed ID: 27122132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repeat lumpectomy for patients with ipsilateral breast tumor recurrence after breast-conserving surgery. Preliminary results.
    Komoike Y; Motomura K; Inaji H; Kasugai T; Koyama H
    Oncology; 2003; 64(1):1-6. PubMed ID: 12457024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Locoregional recurrence of breast cancer in patients treated with breast conservation surgery and radiotherapy following neoadjuvant chemotherapy.
    Min SY; Lee SJ; Shin KH; Park IH; Jung SY; Lee KS; Ro J; Lee S; Kim SW; Kim TH; Kang HS; Cho KH
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e697-705. PubMed ID: 21129858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early response to neo-adjuvant chemotherapy in carcinoma of the breast predicts both successful breast-conserving surgery and decreased risk of ipsilateral breast tumor recurrence.
    Ishitobi M; Komoike Y; Motomura K; Koyama H; Inaji H
    Breast J; 2010; 16(1):9-13. PubMed ID: 19929889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 63.